These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 8971700

  • 1. Glycogen synthase kinase 3 alteration in Alzheimer disease is related to neurofibrillary tangle formation.
    Baum L, Hansen L, Masliah E, Saitoh T.
    Mol Chem Neuropathol; 1996; 29(2-3):253-61. PubMed ID: 8971700
    [Abstract] [Full Text] [Related]

  • 2. Physiology and pathology of tau protein kinases in relation to Alzheimer's disease.
    Imahori K, Uchida T.
    J Biochem; 1997 Feb; 121(2):179-88. PubMed ID: 9089387
    [Abstract] [Full Text] [Related]

  • 3. Overexpressed tau protein in cultured cells is phosphorylated without formation of PHF: implication of phosphoprotein phosphatase involvement.
    Baum L, Seger R, Woodgett JR, Kawabata S, Maruyama K, Koyama M, Silver J, Saitoh T.
    Brain Res Mol Brain Res; 1995 Dec 01; 34(1):1-17. PubMed ID: 8750856
    [Abstract] [Full Text] [Related]

  • 4. The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease.
    Leroy K, Boutajangout A, Authelet M, Woodgett JR, Anderton BH, Brion JP.
    Acta Neuropathol; 2002 Feb 01; 103(2):91-9. PubMed ID: 11810173
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Glycogen synthase kinase-3 beta phosphorylates tau protein at multiple sites in intact cells.
    Sperber BR, Leight S, Goedert M, Lee VM.
    Neurosci Lett; 1995 Sep 08; 197(2):149-53. PubMed ID: 8552282
    [Abstract] [Full Text] [Related]

  • 7. Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain.
    Pei JJ, Tanaka T, Tung YC, Braak E, Iqbal K, Grundke-Iqbal I.
    J Neuropathol Exp Neurol; 1997 Jan 08; 56(1):70-8. PubMed ID: 8990130
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.
    Ferrer I, Blanco R, Carmona M, Puig B.
    J Neural Transm (Vienna); 2001 Jan 08; 108(12):1397-415. PubMed ID: 11810404
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Sites of phosphorylation in tau and factors affecting their regulation.
    Anderton BH, Betts J, Blackstock WP, Brion JP, Chapman S, Connell J, Dayanandan R, Gallo JM, Gibb G, Hanger DP, Hutton M, Kardalinou E, Leroy K, Lovestone S, Mack T, Reynolds CH, Van Slegtenhorst M.
    Biochem Soc Symp; 2001 Jan 08; (67):73-80. PubMed ID: 11447841
    [Abstract] [Full Text] [Related]

  • 14. GSK3 and tau: two convergence points in Alzheimer's disease.
    Hernandez F, Lucas JJ, Avila J.
    J Alzheimers Dis; 2013 Jan 08; 33 Suppl 1():S141-4. PubMed ID: 22710914
    [Abstract] [Full Text] [Related]

  • 15. Compartmentalized tau hyperphosphorylation and increased levels of kinases in transgenic mice.
    Götz J, Nitsch RM.
    Neuroreport; 2001 Jul 03; 12(9):2007-16. PubMed ID: 11435938
    [Abstract] [Full Text] [Related]

  • 16. Increased tau phosphorylation but absence of formation of neurofibrillary tangles in mice double transgenic for human tau and Alzheimer mutant (M146L) presenilin-1.
    Boutajangout A, Leroy K, Touchet N, Authelet M, Blanchard V, Tremp G, Pradier L, Brion JP.
    Neurosci Lett; 2002 Jan 18; 318(1):29-33. PubMed ID: 11786218
    [Abstract] [Full Text] [Related]

  • 17. Extracellular signal regulated kinases. Localization of protein and mRNA in the human hippocampal formation in Alzheimer's disease.
    Hyman BT, Elvhage TE, Reiter J.
    Am J Pathol; 1994 Mar 18; 144(3):565-72. PubMed ID: 8129042
    [Abstract] [Full Text] [Related]

  • 18. The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2Bepsilon at Ser539 and the microtubule-associated protein tau at Thr212: potential role for DYRK as a glycogen synthase kinase 3-priming kinase.
    Woods YL, Cohen P, Becker W, Jakes R, Goedert M, Wang X, Proud CG.
    Biochem J; 2001 May 01; 355(Pt 3):609-15. PubMed ID: 11311121
    [Abstract] [Full Text] [Related]

  • 19. Tau phosphorylation in cells transfected with wild-type or an Alzheimer's disease mutant Presenilin 1.
    Irving NG, Miller CC.
    Neurosci Lett; 1997 Jan 31; 222(2):71-4. PubMed ID: 9111731
    [Abstract] [Full Text] [Related]

  • 20. Increased level of active GSK-3beta in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration.
    Leroy K, Yilmaz Z, Brion JP.
    Neuropathol Appl Neurobiol; 2007 Feb 31; 33(1):43-55. PubMed ID: 17239007
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.